Transgene SA (TRGNF)

USD 1.59

(0.0%)

Revenue Summary of Transgene SA

  • Transgene SA's latest annual revenue in 2023 was 1.18 Million EUR , down -62.12% from previous year.
  • Transgene SA's latest quarterly revenue in 2024 Q2 was 1.67 Million EUR , down 0.0% from previous quarter.
  • Transgene SA reported a annual revenue of 3.12 Million EUR in annual revenue 2022, down -68.72% from previous year.
  • Transgene SA reported a annual revenue of 9.99 Million EUR in annual revenue 2021, up 235.22% from previous year.
  • Transgene SA reported a quarterly revenue of 1.67 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • Transgene SA reported a quarterly revenue of 1.56 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Transgene SA (2023 - 1997)

Historical Annual Revenue of Transgene SA (2023 - 1997)

Year Revenue Revenue Growth
2023 1.18 Million EUR -62.12%
2022 3.12 Million EUR -68.72%
2021 9.99 Million EUR 235.22%
2020 2.98 Million EUR -55.19%
2019 6.65 Million EUR 398.28%
2018 1.33 Million EUR -36.4%
2017 2.09 Million EUR -10.53%
2016 2.34 Million EUR 60.14%
2015 1.46 Million EUR -41.16%
2014 2.49 Million EUR -35.31%
2013 3.84 Million EUR -2.01%
2012 3.92 Million EUR -72.81%
2011 14.44 Million EUR 2.37%
2010 14.11 Million EUR 19.95%
2009 11.76 Million EUR -15.66%
2008 13.94 Million EUR -50.22%
2007 28.01 Million EUR 405.21%
2006 5.54 Million EUR 0.0%
2004 2.51 Million EUR 0.52%
2003 2.5 Million EUR 13.37%
2002 2.2 Million EUR 75.08%
2001 1.26 Million EUR -73.33%
2000 4.72 Million EUR 9.23%
1999 4.32 Million EUR -62.93%
1998 11.66 Million EUR 73.84%
1997 6.71 Million EUR 0.0%

Peer Revenue Comparison of Transgene SA

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 92.494%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -6619.255%
SQZ Biotechnologies Company 21.47 Million USD 94.487%
Evofem Biosciences, Inc. 18.21 Million USD 93.501%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.037%
Mesoblast Limited 5.9 Million USD 79.939%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.823%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -188.664%
Marizyme, Inc. 645.81 Thousand USD -83.336%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -1442.45%
Intellipharmaceutics International Inc. 65.72 Thousand USD -1701.363%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -2896.103%
MultiCell Technologies, Inc. 49.32 USD -2400548.824%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 97.619%
EV Biologics, Inc. 48.9 Thousand USD -2321.268%
Q BioMed Inc. 284.35 Thousand USD -316.385%
Emmaus Life Sciences, Inc. 29.59 Million USD 96.0%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.517%
Oncotelic Therapeutics, Inc. 70 Thousand USD -1591.429%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -1096.032%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -1463.573%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -79.803%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.992%
Halberd Corporation 999.00 USD -118418.519%
Enzolytics Inc. 52.79 Thousand USD -2142.594%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 13.514%
SYBLEU INC 11.69 Thousand USD -10023.119%
Nuo Therapeutics, Inc. 608.52 Thousand USD -94.569%
argenx SE 1.22 Billion USD 99.903%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 38.716%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -91.777%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.859%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.184%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -112.297%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -18.67%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 97.551%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 92.904%
ONE Bio Corp. 52.29 Million USD 97.736%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -400.507%
Regen BioPharma, Inc. 236.56 Thousand USD -400.507%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -744.255%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -149.931%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 84.799%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -9007.692%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -2894.89%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 64.444%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 82.236%
IntelGenx Technologies Corp. 1.03 Million USD -13.956%
Gelesis Holdings, Inc. 25.76 Million USD 95.405%
CSL Limited 14.8 Billion USD 99.992%
Cellectis S.A. 755 Thousand USD -56.821%